These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20222127)

  • 1. IL-23/IL-17 axis in IBD.
    Sarra M; Pallone F; Macdonald TT; Monteleone G
    Inflamm Bowel Dis; 2010 Oct; 16(10):1808-13. PubMed ID: 20222127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
    Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
    World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17-related cytokines in inflammatory bowel diseases: friends or foes?
    Monteleone I; Sarra M; Pallone F; Monteleone G
    Curr Mol Med; 2012 Jun; 12(5):592-7. PubMed ID: 22515978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-23 and Th17 cells in the control of gut inflammation.
    Monteleone I; Pallone F; Monteleone G
    Mediators Inflamm; 2009; 2009():297645. PubMed ID: 19503799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-23/Th17 pathways and inflammatory bowel disease.
    Abraham C; Cho J
    Inflamm Bowel Dis; 2009 Jul; 15(7):1090-100. PubMed ID: 19253307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
    Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
    J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 immune response in IBD: A new pathogenic mechanism.
    Caprioli F; Pallone F; Monteleone G
    J Crohns Colitis; 2008 Dec; 2(4):291-5. PubMed ID: 21172226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
    Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
    Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interleukin-23 axis in intestinal inflammation.
    Ahern PP; Izcue A; Maloy KJ; Powrie F
    Immunol Rev; 2008 Dec; 226():147-59. PubMed ID: 19161422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.
    Troncone E; Marafini I; Pallone F; Monteleone G
    Int Rev Immunol; 2013; 32(5-6):526-33. PubMed ID: 24041379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
    Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis.
    Sheibanie AF; Yen JH; Khayrullina T; Emig F; Zhang M; Tuma R; Ganea D
    J Immunol; 2007 Jun; 178(12):8138-47. PubMed ID: 17548652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.
    Li Q; Shan Q; Sang X; Zhu R; Chen X; Cao G
    Am J Chin Med; 2019; 47(1):177-201. PubMed ID: 30612460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the IL-23/IL-17 axis in Crohn's disease.
    Siakavellas SI; Bamias G
    Discov Med; 2012 Oct; 14(77):253-62. PubMed ID: 23114581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease.
    Hundorfean G; Neurath MF; Mudter J
    Inflamm Bowel Dis; 2012 Jan; 18(1):180-6. PubMed ID: 21381156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.